CHENG CHUNG CHOW: Open Payments
NPI 1811540685 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 6 payments from 6 companies in 2025. Trend: 2023 $112 · 2024 $244 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $132 |
| Gilead Sciences, Inc. | 1 | $130 |
| Stemline Therapeutics Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $123 |
| Merck Sharp & Dohme LLC | 1 | $112 |
| AstraZeneca Pharmaceuticals LP | 1 | $112 |
Products named: Jakafi, Trodelvy, Orserdu, EPKINLY, KEYTRUDA.
Industry payments across FL — which companies pay providers there.
